Shah, Prediman Krishan
- Cedars-Sinai Medical Center · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,722
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#9,722
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Shah, Prediman Krishan as a PI. Multi-PI records show the full award amount for context.
- 5R01HL160860-02R01Contact PIA hypercholesterolemia-induced immunometabolite in atherosclerosisCedars-Sinai Medical Center · Internal Medicine (investigator's affiliation)$616.2Kaward amount
- 5R01HL160908-02R01Contact PIThe role of GATA3-positive macrophages in cardiovascular pathologiesCedars-Sinai Medical Center · Internal Medicine (investigator's affiliation)$417.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Shah, Prediman Krishan as a PI.
FY2023 award administered by Cedars-Sinai Medical Center (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardCedars-Sinai Medical Center
- 2009$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2011$2M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #8710
- 2011R01 Grant Holder
- 2023$5M Cumulative Funding